MetLife Investment Advisors »

Lb Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $247k 11k 22.26

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Meta Platforms Inc Class A Cl A (META)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Visa Inc Class A Com Cl A (V)
Spdr S&p Etf Trust Tr Unit (SPY)

View all positions for MetLife Investment Advisors

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Vanguard Group
Jpmorgan Chase & Co
Balyasny Asset Management
Jennison Associates
Vivo Capital
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management

View all funds holding Lb Pharmaceuticals